Jakson kuvaus
Gout remains poorly managed at the population level despite a well-understood pathophysiology, established serum urate targets, and an expanding pharmacological toolkit, according to a recent episode of the rheumatology podcast Joint Ventures. Hosts Jack Arnold, MBBS, PhD, academic clinical lecturer in rheumatology at the University of Leeds, and Rihards Buss, MD, consultant rheumatologist at Freeman Hospital, Newcastle, reviewed current guidelines, emerging trial data, and the pipeline in gout management.
Sivusto: audioboom.com

